MU
42
14
WFC
58
8
MO
47
6
EXPE
83
8
KO
44
2
BLK
46
2
WBA
41
3
MAC
53
5
GM
55
6
NI
63
5
UPS
51
6
DUK
49
4
NOV
45
2
AZO
46
3
CSCO
63
5
SPG
45
2
V
70
14
NWSA
69
4
STT
48
4
LOW
42
14
MU
42
14
WFC
58
8
MO
47
6
EXPE
83
8
KO
44
2
BLK
46
2
WBA
41
3
MAC
53
5
GM
55
6
NI
63
5
UPS
51
6
DUK
49
4
NOV
45
2
AZO
46
3
CSCO
63
5
SPG
45
2
V
70
14
NWSA
69
4
STT
48
4
LOW
42
14
Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Novo Nordisk AS Price Quote

$84.75
+0.00 (+-17.78%)
(Updated: December 21, 2024 at 5:39 AM ET)

Novo Nordisk AS Key Stats

Sell
13
Novo Nordisk AS (NONOF) is a Sell
Day range:
$79.15 - $86.50
52-week range:
$79.15 - $149.55
Dividend yield:
1.71%
P/E ratio:
31.35
P/S ratio:
9.62
P/B ratio:
20.85%
Volume:
124K
Avg. volume:
75.2K
1-year change:
-16.66%
Market cap:
$376.4B
Revenue:
$33.7B
EPS:
$3.09

How Much Does Novo Nordisk AS Make?

Data Unavailable

Is Novo Nordisk AS Growing As A Company?

Data Unavailable

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went down by -19.66% last month
  • Did NONOF's Share Price Rise Over The Last Year?
    NONOF share price fell by -16.66% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Novo Nordisk AS?

Data Unavailable

Is Novo Nordisk AS Cash Flow Positive?

Data Unavailable

Novo Nordisk AS Return On Invested Capital

Data Unavailable

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

Novo Nordisk AS Dividend Yield

Data Unavailable

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 23.52% 0%
Revenue: 22.53% -0.31%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable